Axcelis Technologies, Inc.
NASDAQ:ACLSSemiconductors
+$11.85 today
- Market cap
- $3.12B
- Beta
- 1.92
- P/E (TTM)
- 57.0
- EPS (TTM)
- $3.28
Volume 0.35M
Average 0.70M
ACLS Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Axcelis Technologies, Inc.NASDAQ: ACLS
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures turns positive
Q3 FY2026 capital expenditures was $5.39M, compared with -$2.02M a year earlier. Trailing-twelve-month capital expenditures was -$2.34M. Over 3 fiscal years it compounded at +1.9% a year.
Context
- Capital expenditures amounted to 1.3% of revenue in FY2025, up 0.1 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly capital expenditures holds near $5.39M or moves back toward the trailing-twelve-month quarterly average of -$583.75K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (11.3M) USD
- Year-over-year change
- +7.3%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (11.3M) | +7.3% |
| FY2024 | 2024-12-31 | (12.18M) | +41.0% |
| FY2023 | 2023-12-31 | (20.66M) | -93.4% |
| FY2022 | 2022-12-31 | (10.68M) | -22.5% |
| FY2021 | 2021-12-31 | (8.72M) | — |
Capital Expenditures vs competitors
How ACLS compares with its peers on the latest reported figures
- ACLS's LTM Sep 2026 capital expenditures of $2.34M is the 10th largest of the 11 companies compared; the peer median is $84.46M.
- Its year-over-year change of -82.9% is the lowest of 11, against a peer median of +2.3%.
- Capital expenditures amounts to 0.3% of revenue for ACLS, versus a peer median of 3.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.04B | +94.3% | +24.4% | 4.0% | |
| LTM Jun 2026 | $375.95M | +11.2% | +3.2% | 2.8% | |
| LTM Jun 2026 | $205.5M | +8.3% | -13.7% | 6.2% | |
| LTM May 2026 | $185.92M | +13.8% | +18.8% | 21.6% | |
| LTM Jun 2026 | $113.53M | +44.6% | -15.3% | 10.9% | |
| LTM Sep 2026 | $55.4M | -3.7% | -20.5% | 2.3% | |
| LTM Sep 2026 | $16.41M | -9.3% | -9.7% | 2.3% | |
| LTM Jul 2026 | $13.99M | -16.3% | -9.2% | 1.5% | |
| LTM Sep 2026 | $13.93M | -50.3% | +15.7% | 1.1% | |
| LTM Sep 2026 | $2.34M | -82.9% | +1.9% | 0.3% | |
| LTM May 2026 | $2.07M | -58.6% | +14.9% | 4.1% | |
| Peer median (excluding ACLS) | $84.46M | +2.3% | -3.0% | 3.4% | |
Competitors are the stored peer set for ACLS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 98.65M | 183.08M | 246.26M | 200.99M | 120.24M |
| Depreciation & Amortization | 10.82M | 11.61M | 13.07M | 15.81M | 17.61M |
| Deferred Income Tax | 20.26M | 8.54M | (20.02M) | (15.59M) | (10.7M) |
| Stock-Based Compensation | 12.07M | 13.44M | 18.27M | 20.95M | 20.77M |
| Change in Working Capital | 4.64M | (11.61M) | (97.23M) | (85.4M) | (30.86M) |
| Accounts Receivables | (18.15M) | (67.27M) | (50.76M) | 6.91M | 37.43M |
| Inventory | (39.02M) | (58.43M) | (69.96M) | 5.92M | (42.22M) |
| Accounts Payables | 22.05M | 31.39M | (8.1M) | (413K) | 6.19M |
| Other Working Capital | 39.77M | 82.7M | 31.59M | (97.82M) | (32.26M) |
| Other Non-Cash Items | 3.76M | 10.55M | (3.49M) | 4.06M | 1.24M |
| Operating Cash Flow | 150.19M | 215.61M | 156.87M | 140.82M | 118.31M |
| Capital Expenditures | (8.72M) | (10.68M) | (20.66M) | (12.18M) | (11.3M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | (246.57M) | (388.81M) | (539.12M) | (646M) |
| Sales of Investments | 0 | 0 | 308.61M | 442.58M | 687.22M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (8.72M) | (257.25M) | (100.86M) | (108.73M) | 29.93M |
| Debt Repayment | (763K) | (987K) | (1.24M) | (1.53M) | (1.36M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 2.46M |
| Common Stock Repurchased | (49.99M) | (57.5M) | (52.5M) | (60.49M) | (121.08M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.7M) | (7M) | (14.53M) | (9.18M) | (4.51M) |
| Financing Cash Flow | (52.45M) | (65.48M) | (68.27M) | (71.19M) | (124.49M) |
| Effect of Forex Changes | 2.43M | (2.21M) | (139K) | (3.79M) | (1.8M) |
| Net Change in Cash | 91.45M | (109.33M) | (12.4M) | (42.89M) | 21.94M |
| Free Cash Flow | 141.47M | 204.92M | 136.21M | 128.64M | 107.01M |
Axcelis Technologies, Inc.
NASDAQ:ACLS
Intrinsic Alpha fair value
Locked
Current Price
$100.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.